IL276008A - Antibodies that increase factor h activity and their uses - Google Patents

Antibodies that increase factor h activity and their uses

Info

Publication number
IL276008A
IL276008A IL276008A IL27600820A IL276008A IL 276008 A IL276008 A IL 276008A IL 276008 A IL276008 A IL 276008A IL 27600820 A IL27600820 A IL 27600820A IL 276008 A IL276008 A IL 276008A
Authority
IL
Israel
Prior art keywords
factor
potentiating antibodies
potentiating
antibodies
Prior art date
Application number
IL276008A
Other languages
English (en)
Hebrew (he)
Inventor
Willem Kuijpers Taco
Wouters Diana
Clara Brouwer Maria
Benjamin Pouw Richard
Original Assignee
Stichting Sanquin Bloedvoorziening
Willem Kuijpers Taco
Wouters Diana
Clara Brouwer Maria
Benjamin Pouw Richard
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting Sanquin Bloedvoorziening, Willem Kuijpers Taco, Wouters Diana, Clara Brouwer Maria, Benjamin Pouw Richard filed Critical Stichting Sanquin Bloedvoorziening
Publication of IL276008A publication Critical patent/IL276008A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/75—Agonist effect on antigen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL276008A 2018-01-15 2020-07-13 Antibodies that increase factor h activity and their uses IL276008A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18151726 2018-01-15
PCT/NL2019/050018 WO2019139481A1 (en) 2018-01-15 2019-01-15 Factor h potentiating antibodies and uses thereof

Publications (1)

Publication Number Publication Date
IL276008A true IL276008A (en) 2020-08-31

Family

ID=60972152

Family Applications (1)

Application Number Title Priority Date Filing Date
IL276008A IL276008A (en) 2018-01-15 2020-07-13 Antibodies that increase factor h activity and their uses

Country Status (11)

Country Link
US (2) US11377487B2 (cg-RX-API-DMAC7.html)
EP (1) EP3740502A1 (cg-RX-API-DMAC7.html)
JP (2) JP7471224B2 (cg-RX-API-DMAC7.html)
KR (2) KR20250171487A (cg-RX-API-DMAC7.html)
CN (1) CN111868083B (cg-RX-API-DMAC7.html)
AU (1) AU2019206207B2 (cg-RX-API-DMAC7.html)
BR (1) BR112020014399A2 (cg-RX-API-DMAC7.html)
CA (1) CA3088507A1 (cg-RX-API-DMAC7.html)
IL (1) IL276008A (cg-RX-API-DMAC7.html)
MX (1) MX2020007555A (cg-RX-API-DMAC7.html)
WO (1) WO2019139481A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2019206207B2 (en) * 2018-01-15 2025-04-10 Stichting Sanquin Bloedvoorziening Factor H potentiating antibodies and uses thereof
JP7631296B2 (ja) * 2019-07-17 2025-02-18 ジェミニ・セラピューティクス・サブ・インコーポレイテッド H因子増強性抗体及びその使用
KR20230113578A (ko) * 2020-11-27 2023-07-31 선샤인 레이크 파르마 컴퍼니 리미티드 Cldn18.2 항체 및 그의 용도
KR20240040098A (ko) * 2021-07-30 2024-03-27 알.피.쉐러 테크놀러지즈 엘엘씨 넥틴-4에 특이적인 항체 및 항체 접합체 및 이의 사용방법
CN116355860A (zh) * 2021-12-28 2023-06-30 四川远大蜀阳药业有限责任公司 分泌抗h因子抗体的杂交瘤细胞株、抗h因子抗体及其应用
CN116655792B (zh) * 2022-03-21 2024-01-02 南京蓬勃生物科技有限公司 靶向Siglec-15的单克隆抗体及其应用
NL2032398B1 (en) * 2022-07-06 2024-01-23 Academisch Ziekenhuis Leiden Bispecific antibody and uses thereof
CN118878671B (zh) * 2024-07-04 2025-09-30 南京农业大学 抗兽疫链球菌SzM蛋白的猪源化单克隆抗体

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8580714B2 (en) 2009-10-14 2013-11-12 Janssen Biotech, Inc. Methods of affinity maturing antibodies
CA2780221A1 (en) 2009-11-04 2011-05-12 Fabrus Llc Methods for affinity maturation-based antibody optimization
AU2015304079B2 (en) 2014-08-20 2021-05-13 Stichting Sanquin Bloedvoorziening Factor H potentiating antibodies and uses thereof
KR102485788B1 (ko) 2014-08-27 2023-01-09 메모리얼 슬로안 케터링 캔서 센터 항체, 조성물 및 용도
AU2019206207B2 (en) * 2018-01-15 2025-04-10 Stichting Sanquin Bloedvoorziening Factor H potentiating antibodies and uses thereof
JP7631296B2 (ja) * 2019-07-17 2025-02-18 ジェミニ・セラピューティクス・サブ・インコーポレイテッド H因子増強性抗体及びその使用

Also Published As

Publication number Publication date
CN111868083A (zh) 2020-10-30
JP2021510523A (ja) 2021-04-30
KR20250171487A (ko) 2025-12-08
AU2019206207A1 (en) 2020-08-13
AU2019206207B2 (en) 2025-04-10
BR112020014399A2 (pt) 2020-12-29
KR102896085B1 (ko) 2025-12-08
US20210054059A1 (en) 2021-02-25
WO2019139481A1 (en) 2019-07-18
US11377487B2 (en) 2022-07-05
EP3740502A1 (en) 2020-11-25
JP2023089191A (ja) 2023-06-27
US20220356235A1 (en) 2022-11-10
KR20200110688A (ko) 2020-09-24
CA3088507A1 (en) 2019-07-18
US12624094B2 (en) 2026-05-12
CN111868083B (zh) 2025-02-11
MX2020007555A (es) 2021-01-15
JP7471224B2 (ja) 2024-04-19

Similar Documents

Publication Publication Date Title
IL282968A (en) Anti-NKG2A antibodies and their use
IL276950A (en) Anti-CD73 antibodies and uses thereof
SG11202105885WA (en) Anti-claudin antibodies and uses thereof
ZA202006904B (en) Anti-il-4r antibody and use thereof
IL275826A (en) Anti-mct1 antibodies and their uses
ZA202006066B (en) Anti-hla-g antibodies and use thereof
SG11202104240TA (en) Cll1-targeting antibody and application thereof
SG11202100746WA (en) Anti-tigit antibody and use thereof
IL289585A (en) DLL3-targeted antibodies and uses thereof
IL291027A (en) Anti-steap1 antibodies and uses thereof
SG11202009772PA (en) Anti-dll3 antibodies and uses thereof
IL280321A (en) Antibodies against CXCR2 and their uses
IL276548A (en) Binding antibodies - BCMA and their uses
SG11202009625WA (en) Anti-trem-1 antibodies and uses thereof
SG11202105161YA (en) Anti-il-27 antibodies and uses thereof
IL281202A (en) Anti-TNFRSF9 antibodies and uses thereof
ZA202100714B (en) Anti-npr1 antibodies and uses thereof
IL277075A (en) Anti-PHF-tau antibodies and uses thereof
IL282707A (en) Anti-tim-3 antibodies and their use
IL277330A (en) Anti-IL-27 antibodies and uses thereof
IL282708A (en) Anti-tim-3 antibodies and their use
SG11202012680TA (en) Anti-l1cam antibodies and uses thereof
IL283926B1 (en) Antibodies against alpha-synuclein and their uses
IL283890A (en) Anti-periostin antibodies and their uses
IL289812A (en) Factor h-enhancing antibodies and their uses